EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Molecular Subtypes of Breast Cancer as Predictors of Lymph Node Metastasis and Disease-Free Survival: A Retrospective Cohort Study

Mohammed Khaled, Tahera Hossain Lifa, Shahnaz Sultana, Md Jahirul Islam

Asia Pacific Journal of Cancer Research · 25.12.2025 · 2 (4) · 138-145

DOI: 10.70818/apjcr.v02i04.063 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Asia Pacific Journal of Cancer Research, online erschienen am 25.12.2025. Verfasst von Mohammed Khaled und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer is the most common malignancy among women worldwide. Molecular subtypes of breast cancer are known to influence tumor aggressiveness, lymph node metastasis, treatment response, and prognosis. However, limited data are available regarding the relationship between molecular subtypes, lymph node involvement, and short-term disease-free survival (DFS) among Bangladeshi women.

Objective

This study aimed to evaluate the association between molecular subtypes of breast cancer and lymph node metastasis, as well as their impact on 12-month disease-free survival among patients in Dhaka, Bangladesh.

Methods

A retrospective cohort study was conducted at Dhaka Medical College Hospital, including 280 women diagnosed with primary invasive breast carcinoma from January 2021 to January 2022. Data on patient demographics, tumor characteristics, immunohistochemical profiles (ER, PR, HER2, Ki-67), lymphovascular invasion (LVI), axillary lymph node status, and follow-up were collected. Tumors were classified into molecular subtypes (Luminal A, Luminal B, HER2-enriched, Triple-negative). Associations with lymph node metastasis were analyzed using Chi-square tests, and DFS was evaluated using Kaplan–Meier survival curves and Cox proportional hazards regression.

Results

Luminal B was the most common molecular subtype (40%), followed by Luminal A (32.9%), Triple-negative (14.3%), and HER2-enriched (12.9%). Lymph node metastasis was highest in HER2-enriched (66.7%) and Triple-negative tumors (60%), and lowest in Luminal A tumors (32.6%) (p

Zitieren

APA

Khaled, M., Lifa, T. H., Sultana, S., & Islam, M. J. (2025). Molecular Subtypes of Breast Cancer as Predictors of Lymph Node Metastasis and Disease-Free Survival: A Retrospective Cohort Study. Asia Pacific Journal of Cancer Research, 2(4), 138-145. https://doi.org/10.70818/apjcr.v02i04.063

Vancouver

Khaled M, Lifa TH, Sultana S, Islam MJ. Molecular Subtypes of Breast Cancer as Predictors of Lymph Node Metastasis and Disease-Free Survival: A Retrospective Cohort Study. Asia Pacific Journal of Cancer Research. 2025;2(4):138-145. doi:10.70818/apjcr.v02i04.063

BibTeX
@article{Khaled2025,
  author = {Khaled, Mohammed and Lifa, Tahera Hossain and Sultana, Shahnaz and Islam, Md Jahirul},
  title = {Molecular Subtypes of Breast Cancer as Predictors of Lymph Node Metastasis and Disease-Free Survival: A Retrospective Cohort Study},
  journal = {Asia Pacific Journal of Cancer Research},
  year = {2025},
  volume = {2},
  number = {4},
  pages = {138--145},
  doi = {10.70818/apjcr.v02i04.063}
}
Kostenlos starten →